Lower prevalence of metabolic syndrome and its components in the prediagnostic phase of Parkinson’s disease
Abstract Investigating the association between metabolic syndrome (MetS) and all its components with prediagnostic Parkinson’s disease (PD) may clarify PD pathogenesis and identify candidates for prevention strategies and neuroprotective trials. We conducted a retrospective study of 890 PD patients...
Saved in:
| Main Authors: | Hila Avisar, Uri Greenbaum, Ruth Djaldetti, Boaz Lerner |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-06-01
|
| Series: | npj Parkinson's Disease |
| Online Access: | https://doi.org/10.1038/s41531-025-01003-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prediagnostic presentations of glioma in primary care: a case–control study
by: Marthe CM Peeters, et al.
Published: (2019-11-01) -
Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer.
by: Fang Fang, et al.
Published: (2011-04-01) -
Prevalence of metabolic syndrome and its components in nondiabetic Libyan females
by: Hawa El-Shareif
Published: (2018-01-01) -
Prevalence of metabolic syndrome and its components in patients with arterial hypertension and obesity
by: I. E. Chazova, et al.
Published: (2005-12-01) -
Prevalence of metabolic syndrome and its components in Iran: an updated meta-analysis
by: Asra Moradkhani, et al.
Published: (2025-01-01)